Sectoral Asset Management logo

Sectoral Asset Management

North America, Quebec, Canada, Montréal

Description

Sectoral Asset Management is a distinguished investment firm based in Montréal, Canada, specializing exclusively in the global healthcare sector. Established with a deep commitment to understanding the complexities of the healthcare industry, the firm manages diverse investment portfolios for institutional and private clients. While widely recognized for its expertise in public equity markets, Sectoral Asset Management also operates a dedicated private equity arm, extending its investment reach to late-stage private companies within the same specialized domain. This dual approach allows the firm to leverage its extensive industry knowledge across the entire lifecycle of healthcare innovation, from established public entities to promising private ventures.

The firm's private equity strategy was formally launched in 2017, marking a strategic expansion into direct investments in private healthcare companies. This initiative culminated in the successful final close of its inaugural fund, Sectoral Healthcare Private Equity Fund I, L.P., in 2021, securing approximately US$200 million in total commitments. This fund is specifically geared towards identifying and investing in late-stage private healthcare companies that exhibit strong fundamentals, possess proven business models, and demonstrate clear pathways to liquidity, typically through an initial public offering (IPO) or an acquisition. Sectoral's investment thesis in private equity emphasizes partnering with companies that are beyond the early development stages, focusing instead on those poised for significant growth and market penetration.

Sectoral Asset Management differentiates itself through its profound, sector-specific expertise and an extensive global network within the healthcare industry. This specialized knowledge is critical for conducting thorough due diligence and providing strategic value-add to its portfolio companies. The firm’s team of investment professionals leverages years of experience in healthcare research and investment to identify attractive opportunities and support the growth of its private equity holdings. By focusing on a niche yet expansive global healthcare market, Sectoral aims to generate superior returns for its investors while contributing to the advancement of the healthcare ecosystem. Their approach underscores a commitment to long-term partnerships and a disciplined investment process tailored to the unique dynamics of the healthcare sector.

Investor Profile

Sectoral Asset Management has backed more than 51 startups, with 2 new investments in the last 12 months alone. The firm has led 14 rounds, about 27% of its total and boasts 23 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, France.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Led 1 rounds in the past year.
  • Typical check size: $5M – $25M.

Stage Focus

  • Series B (35%)
  • Series C (29%)
  • Post Ipo Equity (12%)
  • Series D (8%)
  • Series E (6%)
  • Private Equity (4%)
  • Series A (4%)
  • Series Unknown (2%)

Country Focus

  • United States (73%)
  • United Kingdom (8%)
  • France (6%)
  • Switzerland (6%)
  • Israel (4%)
  • Sweden (4%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Medical Device
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Genetics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sectoral Asset Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 7
CA
North America, Massachusetts, United States, Boston
Co-Investments: 6
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 6
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
RTW Investments
North America, New York, United States, New York
Co-Investments: 5
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 8
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 6
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 7
Brace Pharma
North America, Maryland, United States, Rockville
Co-Investments: 5

Which angels does Sectoral Asset Management often collaborate with?

JC
Europe, Surrey, United Kingdom, Weybridge
Shared Deals: 1
AP
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Sectoral Asset Management?

Neuros Medical

Willoughby, Ohio, United States

Neuros Medical develops neurostimulation therapies for patients suffering with unmet medical needs.

Health CareLife ScienceMedicalMedical DeviceTherapeutics
Series DJul 9, 2025
Amount Raised: $56,000,000
Shoulder Innovations

Holland, Michigan, United States

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

BiotechnologyHealth CareMedical Device
Series EMar 10, 2025
Amount Raised: $40,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
LENZ Therapeutics

Del Mar, California, United States

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Health CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityMar 21, 2024
Amount Raised: $53,500,000
Phagenesis

Manchester, Manchester, United Kingdom

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

BiotechnologyHealth CareMedical
Series DMar 4, 2024
Amount Raised: $42,000,000
Cagent Vascular

Wayne, Pennsylvania, United States

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease.

Health CareMedicalMedical Device
Series CFeb 20, 2024
Amount Raised: $30,000,000
Noctrix Health

San Francisco, California, United States

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

Health CareMedical DeviceTherapeutics
Series CJan 16, 2024
Amount Raised: $40,000,000
CurvaFix

Bellevue, Washington, United States

CurvaFix is a medical device company that is developing a novel solution to an unmet need in orthopedic trauma.

Clinical TrialsHealth CareMedicalMedical Device
Series CJul 14, 2023
Amount Raised: $39,000,000
Boundless Bio

La Jolla, California, United States

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series CMay 16, 2023
Amount Raised: $100,000,000
Garuda Therapeutics

Cambridge, Massachusetts, United States

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BFeb 7, 2023
Amount Raised: $62,000,000